Summit Trail Advisors, LLC Abb Vie Inc. Transaction History

Summit Trail Advisors, LLC

$3.97 Billion
Q3 2024

A detailed history of Summit Trail Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 24,423 shares of ABBV stock, worth $4.4 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

24,423

Previous 20,558 18.8%

Holding current value

$4.4 Million

Previous $3.53 Million 36.78%

% of portfolio

0.12%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $633,241 - $770,410	3,865 Added 18.8%	24,423 $4.82 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $452,605 - $528,542	2,924 Added 16.58%	20,558 $3.53 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $416,810 - $474,916	-2,608 Reduced 12.88%	17,634 $3.21 Million
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $126,592 - $142,572	920 Added 4.76%	20,242 $3.14 Million
Q3 2023 Oct 30, 2023	BUY	$133.59 - $154.65 $240,595 - $278,524	1,801 Added 10.28%	19,322 $2.88 Million
Q2 2023 Jul 25, 2023	BUY	$132.51 - $164.9 $1.44 Million - $1.79 Million	10,856 Added 162.88%	17,521 $2.36 Million
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $57,844 - $66,616	400 Added 6.38%	6,665 $1.06 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $55,600 - $66,679	402 Added 6.86%	6,265 $1.01 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $364,916 - $418,535	2,719 Added 86.48%	5,863 $787,000
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $2,339 - $2,974	-17 Reduced 0.54%	3,144 $482,000
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $94,365 - $117,081	715 Added 29.23%	3,161 $512,000
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $4,619 - $5,844	43 Added 1.79%	2,446 $331,000
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $255,679 - $290,234	2,403 New	2,403 $259,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $288,476 - $389,473	-3,584 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $30.9 Million - $36.2 Million	-359,129 Reduced 99.01%	3,584 $354,000
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $31.2 Million - $36.6 Million	362,713 New	362,713 $31.8 Million
Q1 2019 May 16, 2019	SELL	$77.14 - $90.79 $269,758 - $317,492	-3,497 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $289,913 - $357,541	-3,724 Reduced 51.57%	3,497 $322,000
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $310,918 - $345,643	3,497 Added 93.9%	7,221 $683,000
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $725,781 - $858,763	-8,084 Reduced 68.46%	3,724 $345,000
Q1 2018 May 22, 2018	SELL	$92.01 - $123.21 $90.7 Million - $121 Million	-985,445 Reduced 98.82%	11,808 $997,000
Q1 2018 May 21, 2018	BUY	$92.01 - $123.21 $90.6 Million - $121 Million	984,364 Added 7637.24%	997,253 $997,000
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $1.15 Million - $1.27 Million	12,889	12,889 $1.33 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.

Account

Summit Trail Advisors, LLC Abb Vie Inc. Transaction History